首页 > 最新文献

Scandinavian Journal of Pain最新文献

英文 中文
Response to the Letter by Prof Bordoni. 对博尔多尼教授信函的回复。
IF 1.6 Q2 Medicine Pub Date : 2024-03-07 eCollection Date: 2024-01-01 DOI: 10.1515/sjpain-2024-0005
Hayun Lee, Yuvraj Kukreja, G Niraj
{"title":"Response to the Letter by Prof Bordoni.","authors":"Hayun Lee, Yuvraj Kukreja, G Niraj","doi":"10.1515/sjpain-2024-0005","DOIUrl":"10.1515/sjpain-2024-0005","url":null,"abstract":"","PeriodicalId":47407,"journal":{"name":"Scandinavian Journal of Pain","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140060792","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Post cholecystectomy pain syndrome: Letter to Editor. 胆囊切除术后疼痛综合征:致编辑的信。
IF 1.6 Q2 Medicine Pub Date : 2024-03-07 eCollection Date: 2024-01-01 DOI: 10.1515/sjpain-2024-0001
Bruno Bordoni
{"title":"Post cholecystectomy pain syndrome: Letter to Editor.","authors":"Bruno Bordoni","doi":"10.1515/sjpain-2024-0001","DOIUrl":"10.1515/sjpain-2024-0001","url":null,"abstract":"","PeriodicalId":47407,"journal":{"name":"Scandinavian Journal of Pain","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050679","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Translation, contextual adaptation, and reliability of the Danish Concept of Pain Inventory (COPI-Adult (DK)) - A self-reported outcome measure. 丹麦疼痛概念量表(COPI-Adult (DK))的翻译、环境适应性和可靠性--一种自我报告的结果测量法。
IF 1.6 Q2 Medicine Pub Date : 2024-03-07 eCollection Date: 2024-01-01 DOI: 10.1515/sjpain-2023-0092
Bettina Eiger, Christian L Straszek, Joshua W Pate, Michael Skovdal Rathleff

Objectives: Pain is a growing concern globally, and an individual and societal burden. Pain science education (PSE) is a promising avenue for managing chronic pain, but targeted PSE is needed. The Concept of Pain Inventory for Adults (COPI-Adult) is a newly developed self-reported outcome measure aimed at targeting PSE. It is currently unavailable in Danish and has unknown reliability. The aims of this study were (1) to translate and contextually adapt to Danish and (2) to determine reliability in terms of test-retest reliability, internal consistency, and measurement error.

Methods: Step (1) was as follows: a dual panel approach was used to translate, contextually adapt into a Danish version. Step (2) was follows: a heterogenic sample of Danish adults >18 years (n = 150) was included in the test-retest analysis, test interval between 7 and 14 days, both answered via REDCap-link. Based on COSMIN recommendations, the following reliabilities were estimated: the test-retest using intraclass correlation coefficient (ICC2.1) and internal consistency using Cronbach's alpha level. Measurement error in terms of standard error of measurement (SEM) and smallest detectable change (SDC) were calculated.

Results: Step (1) was as follows: the first panel reached 100% consensus on the wording of the COPI-Adult (DK), with no alterations by the second panel. Step (2) was as follows: good to excellent test-retest reliability was found with ICC2.1 value (95% confidence interval) 0.88 (0.84-0.91), excellent internal consistency for the 13-item COPI-Adult (DK) with α = 0.939, SEM of 2.53, and SDC of 7.02.

Discussion: The COPI-Adult (DK) was successfully translated and contextually adapted. It is a reliable questionnaire with excellent internal consistency. The COPI-Adult (DK) shows promise in research and clinical practice.

目的:疼痛是全球日益关注的问题,也是个人和社会的负担。疼痛科学教育(PSE)是管理慢性疼痛的一个很有前景的途径,但需要有针对性的疼痛科学教育。成人疼痛概念量表(COPI-Adult)是一种新开发的自我报告结果测量方法,旨在开展有针对性的 PSE。目前还没有丹麦语版本,其可靠性尚不清楚。本研究的目的是:(1) 翻译并根据丹麦语语境进行调整;(2) 从测试再测可靠性、内部一致性和测量误差等方面确定可靠性:步骤(1)如下:采用双小组方法翻译并根据具体情况调整为丹麦语版本。步骤(2)如下:将年龄大于 18 岁的丹麦成年人(n = 150)纳入重复测试分析,测试间隔为 7 至 14 天,均通过 REDCap-link 进行回答。根据 COSMIN 的建议,对以下可靠性进行了估算:使用类内相关系数(ICC2.1)对重测进行估算,使用 Cronbach's alpha 水平对内部一致性进行估算。以测量标准误差(SEM)和可检测到的最小变化(SDC)为单位计算测量误差:步骤(1)如下:第一小组就 COPI-成人(DK)的措辞达成了 100% 的共识,第二小组未作任何修改。步骤(2)如下:ICC2.1 值(95% 置信区间)为 0.88(0.84-0.91),13 项 COPI-Adult (DK) 的内部一致性极佳,α = 0.939,SEM 为 2.53,SDC 为 7.02:COPI-Adult (DK) 已被成功翻译并根据实际情况进行了调整。它是一份可靠的问卷,具有良好的内部一致性。COPI-Adult (DK) 在研究和临床实践中大有可为。
{"title":"Translation, contextual adaptation, and reliability of the Danish Concept of Pain Inventory (COPI-Adult (DK)) - A self-reported outcome measure.","authors":"Bettina Eiger, Christian L Straszek, Joshua W Pate, Michael Skovdal Rathleff","doi":"10.1515/sjpain-2023-0092","DOIUrl":"10.1515/sjpain-2023-0092","url":null,"abstract":"<p><strong>Objectives: </strong>Pain is a growing concern globally, and an individual and societal burden. Pain science education (PSE) is a promising avenue for managing chronic pain, but targeted PSE is needed. The Concept of Pain Inventory for Adults (COPI-Adult) is a newly developed self-reported outcome measure aimed at targeting PSE. It is currently unavailable in Danish and has unknown reliability. The aims of this study were (1) to translate and contextually adapt to Danish and (2) to determine reliability in terms of test-retest reliability, internal consistency, and measurement error.</p><p><strong>Methods: </strong>Step (1) was as follows: a dual panel approach was used to translate, contextually adapt into a Danish version. Step (2) was follows: a heterogenic sample of Danish adults >18 years (<i>n</i> = 150) was included in the test-retest analysis, test interval between 7 and 14 days, both answered via REDCap-link. Based on COSMIN recommendations, the following reliabilities were estimated: the test-retest using intraclass correlation coefficient (ICC<sub>2.1</sub>) and internal consistency using Cronbach's alpha level. Measurement error in terms of standard error of measurement (SEM) and smallest detectable change (SDC) were calculated.</p><p><strong>Results: </strong>Step (1) was as follows: the first panel reached 100% consensus on the wording of the COPI-Adult (DK), with no alterations by the second panel. Step (2) was as follows: good to excellent test-retest reliability was found with ICC<sub>2.1</sub> value (95% confidence interval) 0.88 (0.84-0.91), excellent internal consistency for the 13-item COPI-Adult (DK) with α = 0.939, SEM of 2.53, and SDC of 7.02.</p><p><strong>Discussion: </strong>The COPI-Adult (DK) was successfully translated and contextually adapted. It is a reliable questionnaire with excellent internal consistency. The COPI-Adult (DK) shows promise in research and clinical practice.</p>","PeriodicalId":47407,"journal":{"name":"Scandinavian Journal of Pain","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2024-03-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140060794","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between self-reported pain severity and characteristics of United States adults (age ≥50 years) who used opioids. 使用阿片类药物的美国成年人(年龄≥50 岁)自我报告的疼痛严重程度与特征之间的关系。
IF 1.6 Q2 Medicine Pub Date : 2024-03-06 eCollection Date: 2024-01-01 DOI: 10.1515/sjpain-2023-0076
David R Axon, Oiza Aliu

Objective: The aim of this study was to assess the associations between the characteristics of United States (US) adults (≥50 years) who used opioids and self-reported pain severity using a nationally representative dataset.

Methods: This retrospective cross-sectional database study used 2019 Medical Expenditure Panel Survey data to identify US adults aged ≥50 years with self-reported pain within the past 4 weeks and ≥1 opioid prescription within the calendar year (n = 1,077). Weighted multivariable logistic regression analysis modeled associations between various characteristics and self-reported pain severity (quite a bit/extreme vs less/moderate pain).

Results: The adjusted logistic regression model indicated that greater odds of reporting quite a bit/extreme pain was associated with the following: age 50-64 vs ≥65 (adjusted odds ratio [AOR] = 1.76; 95% confidence interval [CI] = 1.22-2.54), non-Hispanic vs Hispanic (AOR = 2.0; CI = 1.18-3.39), unemployed vs employed (AOR = 2.01; CI = 1.33-3.05), no health insurance vs private insurance (AOR = 6.80; CI = 1.43-32.26), fair/poor vs excellent/very good/good health (AOR = 3.10; CI = 2.19-4.39), fair/poor vs excellent/very good/good mental health (AOR = 2.16; CI = 1.39-3.38), non-smoker vs smoker (AOR = 1.80; CI = 1.19-2.71), and instrumental activity of daily living, yes vs no (AOR = 2.27; CI = 1.30-3.96).

Conclusion: Understanding the several characteristics associated with pain severity in US adults ≥50 years who used an opioid may help transform healthcare approaches to prevention, education, and management of pain severity in later life.

研究目的本研究旨在利用具有全国代表性的数据集,评估使用阿片类药物的美国成年人(≥50 岁)的特征与自我报告的疼痛严重程度之间的关联:这项回顾性横断面数据库研究使用了2019年医疗支出小组调查数据,以识别年龄≥50岁、在过去4周内自述疼痛且在历年内≥1次阿片类药物处方的美国成年人(n = 1,077)。加权多变量逻辑回归分析模拟了各种特征与自述疼痛严重程度(非常/极度疼痛与较轻/中度疼痛)之间的关系:05)、无医疗保险 vs 私人保险(AOR = 6.80;CI = 1.43-32.26)、健康状况一般/差 vs 优秀/非常好/良好(AOR = 3.10;CI = 2.19-4.39)、心理健康状况一般/差 vs 优秀/非常好/良好(AOR = 2.16;CI = 1.39-3.38)、非吸烟者 vs 吸烟者(AOR = 1.80;CI = 1.19-2.71)和日常生活工具活动,是 vs 否(AOR = 2.27;CI = 1.30-3.96):了解使用过阿片类药物的 50 岁以上美国成年人中与疼痛严重程度相关的几个特征可能有助于改变晚年疼痛严重程度的预防、教育和管理的医疗保健方法。
{"title":"Association between self-reported pain severity and characteristics of United States adults (age ≥50 years) who used opioids.","authors":"David R Axon, Oiza Aliu","doi":"10.1515/sjpain-2023-0076","DOIUrl":"10.1515/sjpain-2023-0076","url":null,"abstract":"<p><strong>Objective: </strong>The aim of this study was to assess the associations between the characteristics of United States (US) adults (≥50 years) who used opioids and self-reported pain severity using a nationally representative dataset.</p><p><strong>Methods: </strong>This retrospective cross-sectional database study used 2019 Medical Expenditure Panel Survey data to identify US adults aged ≥50 years with self-reported pain within the past 4 weeks and ≥1 opioid prescription within the calendar year (<i>n</i> = 1,077). Weighted multivariable logistic regression analysis modeled associations between various characteristics and self-reported pain severity (quite a bit/extreme vs less/moderate pain).</p><p><strong>Results: </strong>The adjusted logistic regression model indicated that greater odds of reporting quite a bit/extreme pain was associated with the following: age 50-64 vs ≥65 (adjusted odds ratio [AOR] = 1.76; 95% confidence interval [CI] = 1.22-2.54), non-Hispanic vs Hispanic (AOR = 2.0; CI = 1.18-3.39), unemployed vs employed (AOR = 2.01; CI = 1.33-3.05), no health insurance vs private insurance (AOR = 6.80; CI = 1.43-32.26), fair/poor vs excellent/very good/good health (AOR = 3.10; CI = 2.19-4.39), fair/poor vs excellent/very good/good mental health (AOR = 2.16; CI = 1.39-3.38), non-smoker vs smoker (AOR = 1.80; CI = 1.19-2.71), and instrumental activity of daily living, yes vs no (AOR = 2.27; CI = 1.30-3.96).</p><p><strong>Conclusion: </strong>Understanding the several characteristics associated with pain severity in US adults ≥50 years who used an opioid may help transform healthcare approaches to prevention, education, and management of pain severity in later life.</p>","PeriodicalId":47407,"journal":{"name":"Scandinavian Journal of Pain","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2024-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140060836","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Confirmatory study of the usefulness of quantum molecular resonance and microdissectomy for the treatment of lumbar radiculopathy in a prospective cohort at 6 months follow-up. 量子分子共振和显微解剖术对腰椎病治疗作用的确认性研究(前瞻性队列,随访 6 个月)。
IF 1.6 Q2 Medicine Pub Date : 2024-03-06 eCollection Date: 2024-01-01 DOI: 10.1515/sjpain-2023-0077
Ángeles Canós-Verdecho, Ruth Robledo, Rosa Izquierdo, Ara Bermejo, Elisa Gallach, David Abejón, Pilar Argente, Isabel Peraita-Costa, María Morales-Suárez-Varela

Objectives: Low back pain is a common musculoskeletal complaint and while prognosis is usually favorable, some patients experience persistent pain despite conservative treatment and invasive treatment to target the root cause of the pain may be necessary. The aim of this study is to evaluate patient outcomes after treatment of lumbar radiculopathy (LR) with quantum molecular resonance radiofrequency coblation disc decompression and percutaneous microdiscectomy with grasper forceps (QMRG).

Methods: This prospective cohort study was carried out in two Spanish hospitals on 58 patients with LR secondary to a contained hydrated lumbar disc hernia or lumbar disc protrusion of more than 6 months of evolution, which persisted despite conservative treatment with analgesia, rehabilitation, and physiotherapy, and/or epidural block, in the previous 2 years. Patients were treated with QMRG and the outcomes were measured mainly using the Douleur Neuropathique en 4 Questions, Numeric Rating Scale, Oswestry Disability Index, SF12: Short Form 12 Health Survey, Patient Global Impression of Improvement, Clinical Global Impression of Improvement, and Medical Outcomes Study Sleep Scale.

Results: Patients who received QMRG showed significant improvement in their baseline scores at 6 months post-treatment. The minimal clinically important difference (MCID) threshold was met by 26-98% of patients, depending on the outcome measure, for non-sleep-related outcomes, and between 17 and 62% for sleep-related outcome measures. Of the 14 outcome measures studied, at least 50% of the patients met the MCID threshold in 8 of them.

Conclusion: Treatment of LR with QMRG appears to be effective at 6 months post-intervention.

目的:腰痛是一种常见的肌肉骨骼疾病,虽然预后通常良好,但有些患者在接受保守治疗后仍会出现持续性疼痛,因此可能需要针对疼痛根源进行侵入性治疗。本研究旨在评估量子分子共振射频钴化椎间盘减压术和带抓钳的经皮显微椎间盘切除术(QMRG)治疗腰椎病(LR)后的患者预后:这项前瞻性队列研究是在两家西班牙医院进行的,对象是 58 名因腰椎间盘水肿疝或腰椎间盘突出而继发的腰椎间盘突出症患者,病程超过 6 个月,尽管在过去两年中接受了镇痛、康复、理疗和/或硬膜外阻滞等保守治疗,但病情仍持续存在。患者接受了 QMRG 治疗,治疗结果主要通过四项问题神经病变评分量表、数字评分量表、Oswestry 残疾指数、SF12:简表 12 健康调查、患者总体改善印象、临床总体改善印象和医疗结果研究睡眠量表进行测量:结果:接受 QMRG 治疗的患者在治疗后 6 个月的基线评分有明显改善。对于非睡眠相关结果,26%-98%的患者达到了最小临床重要差异(MCID)阈值,具体取决于结果测量指标;对于睡眠相关结果,17%-62%的患者达到了最小临床重要差异(MCID)阈值。在研究的 14 项结果指标中,至少有 50%的患者在其中 8 项达到了 MCID 临界值:结论:在干预后 6 个月,使用 QMRG 治疗 LR 似乎是有效的。
{"title":"Confirmatory study of the usefulness of quantum molecular resonance and microdissectomy for the treatment of lumbar radiculopathy in a prospective cohort at 6 months follow-up.","authors":"Ángeles Canós-Verdecho, Ruth Robledo, Rosa Izquierdo, Ara Bermejo, Elisa Gallach, David Abejón, Pilar Argente, Isabel Peraita-Costa, María Morales-Suárez-Varela","doi":"10.1515/sjpain-2023-0077","DOIUrl":"10.1515/sjpain-2023-0077","url":null,"abstract":"<p><strong>Objectives: </strong>Low back pain is a common musculoskeletal complaint and while prognosis is usually favorable, some patients experience persistent pain despite conservative treatment and invasive treatment to target the root cause of the pain may be necessary. The aim of this study is to evaluate patient outcomes after treatment of lumbar radiculopathy (LR) with quantum molecular resonance radiofrequency coblation disc decompression and percutaneous microdiscectomy with grasper forceps (QMRG).</p><p><strong>Methods: </strong>This prospective cohort study was carried out in two Spanish hospitals on 58 patients with LR secondary to a contained hydrated lumbar disc hernia or lumbar disc protrusion of more than 6 months of evolution, which persisted despite conservative treatment with analgesia, rehabilitation, and physiotherapy, and/or epidural block, in the previous 2 years. Patients were treated with QMRG and the outcomes were measured mainly using the Douleur Neuropathique en 4 Questions, Numeric Rating Scale, Oswestry Disability Index, SF12: Short Form 12 Health Survey, Patient Global Impression of Improvement, Clinical Global Impression of Improvement, and Medical Outcomes Study Sleep Scale.</p><p><strong>Results: </strong>Patients who received QMRG showed significant improvement in their baseline scores at 6 months post-treatment. The minimal clinically important difference (MCID) threshold was met by 26-98% of patients, depending on the outcome measure, for non-sleep-related outcomes, and between 17 and 62% for sleep-related outcome measures. Of the 14 outcome measures studied, at least 50% of the patients met the MCID threshold in 8 of them.</p><p><strong>Conclusion: </strong>Treatment of LR with QMRG appears to be effective at 6 months post-intervention.</p>","PeriodicalId":47407,"journal":{"name":"Scandinavian Journal of Pain","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2024-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050674","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fatigue and cognitive fatigability in patients with chronic pain. 慢性疼痛患者的疲劳和认知疲劳。
IF 1.6 Q2 Medicine Pub Date : 2024-03-06 eCollection Date: 2024-01-01 DOI: 10.1515/sjpain-2023-0085
Anna Holmqvist, Nils Berginström, Monika Löfgren, Britt-Marie Stålnacke, Marika C Möller

Objectives: Fatigue is common in patients with chronic pain. Still, there is a lack of studies examining objectively measurable cognitive aspects of fatigue: cognitive fatigability (CF). We aimed to investigate the presence of CF in patients with chronic pain and its relation to self-rated fatigue, attention, pain characteristics, sleep disturbance, depression, and anxiety.

Methods: Two hundred patients with chronic pain and a reference group of 36 healthy subjects underwent a comprehensive neuropsychological test battery, including measurement of CF with the Wechsler Adult Intelligence Scale-III Coding subtest, and self-assessment of trait and state fatigue.

Results: The patients with chronic pain did not show more CF as compared to the reference group. There was an association between CF and processing speed on a test of sustained and selective attention in the chronic pain group, while self-rated fatigue measures and pain characteristics were not associated with CF. Self-rated fatigue measures were highly correlated with self-rated pain intensity, spreading of pain, depression, anxiety, and sleep disturbance.

Conclusions: The findings highlight the distinction between objective and subjective aspects of fatigue in chronic pain, and that the underlying causes of these different aspects of fatigue need to be studied further.

目的:疲劳在慢性疼痛患者中很常见。但目前仍缺乏对疲劳的客观认知方面:认知疲劳(CF)的研究。我们的目的是调查慢性疼痛患者是否存在认知疲劳及其与自评疲劳、注意力、疼痛特征、睡眠障碍、抑郁和焦虑的关系:方法:200 名慢性疼痛患者和由 36 名健康受试者组成的参照组接受了全面的神经心理学测试,包括韦氏成人智力量表-III 编码子测试的 CF 测量,以及特质和状态疲劳的自我评估:结果:与参照组相比,慢性疼痛患者并没有表现出更多的慢性疲劳。在持续和选择性注意力测试中,慢性疼痛组的CF与处理速度之间存在关联,而自评疲劳测量和疼痛特征与CF无关。自评疲劳度与自评疼痛强度、疼痛扩散、抑郁、焦虑和睡眠障碍高度相关:结论:研究结果强调了慢性疼痛患者疲劳的客观和主观方面之间的区别,疲劳的这些不同方面的根本原因需要进一步研究。
{"title":"Fatigue and cognitive fatigability in patients with chronic pain.","authors":"Anna Holmqvist, Nils Berginström, Monika Löfgren, Britt-Marie Stålnacke, Marika C Möller","doi":"10.1515/sjpain-2023-0085","DOIUrl":"10.1515/sjpain-2023-0085","url":null,"abstract":"<p><strong>Objectives: </strong>Fatigue is common in patients with chronic pain. Still, there is a lack of studies examining objectively measurable cognitive aspects of fatigue: cognitive fatigability (CF). We aimed to investigate the presence of CF in patients with chronic pain and its relation to self-rated fatigue, attention, pain characteristics, sleep disturbance, depression, and anxiety.</p><p><strong>Methods: </strong>Two hundred patients with chronic pain and a reference group of 36 healthy subjects underwent a comprehensive neuropsychological test battery, including measurement of CF with the Wechsler Adult Intelligence Scale-III Coding subtest, and self-assessment of trait and state fatigue.</p><p><strong>Results: </strong>The patients with chronic pain did not show more CF as compared to the reference group. There was an association between CF and processing speed on a test of sustained and selective attention in the chronic pain group, while self-rated fatigue measures and pain characteristics were not associated with CF. Self-rated fatigue measures were highly correlated with self-rated pain intensity, spreading of pain, depression, anxiety, and sleep disturbance.</p><p><strong>Conclusions: </strong>The findings highlight the distinction between objective and subjective aspects of fatigue in chronic pain, and that the underlying causes of these different aspects of fatigue need to be studied further.</p>","PeriodicalId":47407,"journal":{"name":"Scandinavian Journal of Pain","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2024-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050676","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Exploring the outcome "days with bothersome pain" and its association with pain intensity, disability, and quality of life. 探索 "疼痛困扰天数 "这一结果及其与疼痛强度、残疾和生活质量的关联。
IF 1.6 Q2 Medicine Pub Date : 2024-03-06 eCollection Date: 2024-01-01 DOI: 10.1515/sjpain-2023-0049
Anne Marie Gausel, Ingvild Dalen, Andreas Eklund, Andreas Hoff Norvik, Iben Axén

Objectives: The aim of this study is to investigate the criterion validity, specifically the concurrent validity of the measure of days with bothersome pain, by investigating its association with measures of pain intensity, disability, and quality of life.

Methods: We used two separate cohorts to study the concurrent validity of "days with bothersome pain," by investigating its association with pain intensity, disability, and quality of life: (1) 321 patients with low back pain (LBP), using follow-up data at 1 year, and (2) 170 pregnant women with pelvic girdle pain (PGP), using data at 12 and 30 weeks of their pregnancy. In both studies, weekly text messages asked for the number of days with bothersome pain the previous week. Pearson's correlation, univariable, and multivariable linear regression were used to assess the association between days with bothersome pain per week and pain intensity, disability, and quality of life. Non-linear associations were explored.

Results: Days with bothersome pain were moderately and inversely correlated with quality of life (r = -0.45, p < 0.001), and moderately correlated with pain intensity (r = 0.70, p < 0.001) and disability ( r = 0.51, p < 0.001), among patients with LBP, and to a lesser degree among pregnant women with PGP (corresponding values at 18 weeks of pregnancy for quality of life; r = -0.27, p = 0.005, for pain intensity r = 0.41, p < 0.001, and for disability r = 0.41, p < 0.001). Furthermore, it was best explained by pain intensity for LBP patients, and by pain intensity and disability for pregnant women with pelvic pain. For the latter cohort, non-linear analyses suggested that days with bothersome pain could not distinguish between individuals with different high pain intensities and disabilities and low quality of life.

Conclusions: We consider the concurrent validity of "days with bothersome pain" to be moderate in the correlations with pain intensity, disability, and quality of life in patients with LBP and in pregnant women with PGP. Ceiling effects may be an issue in populations with high pain severity. The differences between the cohorts suggested that also other constructs are involved in the concept of days with bothersome pain.

研究目的本研究的目的是通过调查 "令人烦恼的疼痛天数 "与疼痛强度、残疾程度和生活质量的相关性,研究其标准效度,特别是并发效度:我们使用两个不同的队列来研究 "令人烦恼的疼痛天数 "的并发有效性,调查其与疼痛强度、残疾和生活质量的关联:(1)321 名腰背痛(LBP)患者,使用 1 年的随访数据;(2)170 名骨盆腰痛(PGP)孕妇,使用怀孕 12 周和 30 周的数据。在这两项研究中,每周的短信都会询问前一周出现疼痛的天数。采用皮尔逊相关性、单变量和多变量线性回归来评估每周疼痛天数与疼痛强度、残疾和生活质量之间的关系。研究还探讨了非线性关联:结果:在腰椎间盘突出症患者中,困扰性疼痛天数与生活质量呈中度反相关(r = -0.45,p < 0.001),与疼痛强度(r = 0.70,p < 0.001)和残疾(r = 0.51,p < 0.001),在患有肺结核的患者中,与生活质量的相关性较低,在患有肺结核的孕妇中,与生活质量的相关性较低(在怀孕 18 周时,生活质量的相应值为 r = -0.27,p = 0.005;疼痛强度的相关性为 r = 0.41,p < 0.001;残疾程度的相关性为 r = 0.41,p < 0.001)。此外,对腰椎间盘突出症患者来说,疼痛强度能最好地解释疼痛强度,而对患有骨盆疼痛的孕妇来说,疼痛强度和残疾程度能最好地解释疼痛强度。对于后者,非线性分析表明,"令人烦恼的疼痛天数 "并不能区分不同的高疼痛强度、残疾和低生活质量的个体:我们认为,"令人烦恼的疼痛天数 "与腰椎间盘突出症患者和患有前列腺增生症的孕妇的疼痛强度、残疾程度和生活质量之间的相关性具有中等程度的并发有效性。在疼痛严重程度较高的人群中,上限效应可能是一个问题。不同组群之间的差异表明,"令人烦恼的疼痛天数 "这一概念还涉及到其他结构。
{"title":"Exploring the outcome \"days with bothersome pain\" and its association with pain intensity, disability, and quality of life.","authors":"Anne Marie Gausel, Ingvild Dalen, Andreas Eklund, Andreas Hoff Norvik, Iben Axén","doi":"10.1515/sjpain-2023-0049","DOIUrl":"10.1515/sjpain-2023-0049","url":null,"abstract":"<p><strong>Objectives: </strong>The aim of this study is to investigate the criterion validity, specifically the concurrent validity of the measure of days with bothersome pain, by investigating its association with measures of pain intensity, disability, and quality of life.</p><p><strong>Methods: </strong>We used two separate cohorts to study the concurrent validity of \"days with bothersome pain,\" by investigating its association with pain intensity, disability, and quality of life: (1) 321 patients with low back pain (LBP), using follow-up data at 1 year, and (2) 170 pregnant women with pelvic girdle pain (PGP), using data at 12 and 30 weeks of their pregnancy. In both studies, weekly text messages asked for the number of days with bothersome pain the previous week. Pearson's correlation, univariable, and multivariable linear regression were used to assess the association between days with bothersome pain per week and pain intensity, disability, and quality of life. Non-linear associations were explored.</p><p><strong>Results: </strong>Days with bothersome pain were moderately and inversely correlated with quality of life (<i>r</i> = -0.45, <i>p</i> < 0.001), and moderately correlated with pain intensity (<i>r</i> = 0.70, <i>p</i> < 0.001) and disability ( <i>r</i> = 0.51, <i>p</i> < 0.001), among patients with LBP, and to a lesser degree among pregnant women with PGP (corresponding values at 18 weeks of pregnancy for quality of life; <i>r</i> = -0.27, <i>p</i> = 0.005, for pain intensity <i>r</i> = 0.41, <i>p</i> < 0.001, and for disability <i>r</i> = 0.41, <i>p</i> < 0.001). Furthermore, it was best explained by pain intensity for LBP patients, and by pain intensity and disability for pregnant women with pelvic pain. For the latter cohort, non-linear analyses suggested that days with bothersome pain could not distinguish between individuals with different high pain intensities and disabilities and low quality of life.</p><p><strong>Conclusions: </strong>We consider the concurrent validity of \"days with bothersome pain\" to be moderate in the correlations with pain intensity, disability, and quality of life in patients with LBP and in pregnant women with PGP. Ceiling effects may be an issue in populations with high pain severity. The differences between the cohorts suggested that also other constructs are involved in the concept of days with bothersome pain.</p>","PeriodicalId":47407,"journal":{"name":"Scandinavian Journal of Pain","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2024-03-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140050675","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cutaneous nerve biopsy in patients with symptoms of small fiber neuropathy: a retrospective study. 小纤维神经病症状患者的皮神经活检:一项回顾性研究。
IF 1.6 Q2 Medicine Pub Date : 2024-02-22 eCollection Date: 2024-01-01 DOI: 10.1515/sjpain-2023-0071
Sissel Løseth, Maria Nebuchennykh, Ruth Therese Brokstad, Sigurd Lindal, Svein Ivar Mellgren

Objectives: We aimed to investigate to what extent small fiber tests were abnormal in an unselected retrospective patient material with symptoms suggesting that small fiber neuropathy (SFN) could be present, and to evaluate possible gender differences.

Methods: Nerve conduction studies (NCS), skin biopsy for determination of intraepidermal nerve fiber density (IENFD) and quantitative sensory testing (QST) were performed. Z-scores were calculated from reference materials to adjust for the effects of age and gender/height.

Results: Two hundred and three patients, 148 females and 55 males had normal NCS and were considered to have possible SFN. 45.3 % had reduced IENFD, 43.2 % of the females and 50.9 % of the males. Mean IENFD was 7.3 ± 2.6 fibers/mm in females and 6.1 ± 2.3 in males (p<0.001), but the difference was not significant when adopting Z-scores. Comparison of gender differences between those with normal and abnormal IENFD were not significant when Z-scores were applied. QST was abnormal in 50 % of the patients (48.9 % in females and 52.9 % in males). In the low IENFD group 45 cases out of 90 (50 %) were recorded with abnormal QST. In those with normal IENFD 51 of 102 (50 %) showed abnormal QST.

Conclusions: Less than half of these patients had reduced IENFD, and 50 % had abnormal QST. There were no gender differences. A more strict selection of patients might have increased the sensitivity, but functional changes in unmyelinated nerve fibers are also known to occur with normal IENFD. Approval to collect data was given by the Norwegian data protection authority at University Hospital of North Norway (Project no. 02028).

目的:我们的目的是调查在未选择的回顾性患者材料中,小纤维检测在多大程度上出现异常:我们的目的是调查在一份未经选择的回顾性患者材料中,小纤维测试在多大程度上出现异常,这些患者的症状表明可能存在小纤维神经病(SFN),并评估可能存在的性别差异:方法:进行神经传导研究(NCS)、皮肤活检以确定表皮内神经纤维密度(IENFD)和定量感觉测试(QST)。根据参考资料计算 Z 值,以调整年龄和性别/身高的影响:23 名患者(148 名女性和 55 名男性)NCS 正常,被认为可能患有 SFN。45.3% 的女性和 50.9% 的男性的 IENFD 有所降低。女性的平均 IENFD 为 7.3 ± 2.6 纤维/毫米,男性为 6.1 ± 2.3 纤维/毫米(pZ-分数)。如果采用 Z 值,IENFD 正常和异常者之间的性别差异比较不显著。50% 的患者 QST 异常(女性 48.9%,男性 52.9%)。在低 IENFD 组中,90 例中有 45 例(50%)QST 异常。在 IENFD 正常的 102 例患者中,有 51 例(50%)出现 QST 异常:结论:不到一半的患者 IENFD 下降,50% 的患者 QST 异常。没有性别差异。对患者进行更严格的筛选可能会提高灵敏度,但已知正常 IENFD 也会导致无髓鞘神经纤维发生功能性变化。北挪威大学医院的挪威数据保护机构已批准收集数据(项目编号:02028)。
{"title":"Cutaneous nerve biopsy in patients with symptoms of small fiber neuropathy: a retrospective study.","authors":"Sissel Løseth, Maria Nebuchennykh, Ruth Therese Brokstad, Sigurd Lindal, Svein Ivar Mellgren","doi":"10.1515/sjpain-2023-0071","DOIUrl":"10.1515/sjpain-2023-0071","url":null,"abstract":"<p><strong>Objectives: </strong>We aimed to investigate to what extent small fiber tests were abnormal in an unselected retrospective patient material with symptoms suggesting that small fiber neuropathy (SFN) could be present, and to evaluate possible gender differences.</p><p><strong>Methods: </strong>Nerve conduction studies (NCS), skin biopsy for determination of intraepidermal nerve fiber density (IENFD) and quantitative sensory testing (QST) were performed. <i>Z</i>-scores were calculated from reference materials to adjust for the effects of age and gender/height.</p><p><strong>Results: </strong>Two hundred and three patients, 148 females and 55 males had normal NCS and were considered to have possible SFN. 45.3 % had reduced IENFD, 43.2 % of the females and 50.9 % of the males. Mean IENFD was 7.3 ± 2.6 fibers/mm in females and 6.1 ± 2.3 in males (p<0.001), but the difference was not significant when adopting <i>Z</i>-scores. Comparison of gender differences between those with normal and abnormal IENFD were not significant when <i>Z</i>-scores were applied. QST was abnormal in 50 % of the patients (48.9 % in females and 52.9 % in males). In the low IENFD group 45 cases out of 90 (50 %) were recorded with abnormal QST. In those with normal IENFD 51 of 102 (50 %) showed abnormal QST.</p><p><strong>Conclusions: </strong>Less than half of these patients had reduced IENFD, and 50 % had abnormal QST. There were no gender differences. A more strict selection of patients might have increased the sensitivity, but functional changes in unmyelinated nerve fibers are also known to occur with normal IENFD. Approval to collect data was given by the Norwegian data protection authority at University Hospital of North Norway (Project no. 02028).</p>","PeriodicalId":47407,"journal":{"name":"Scandinavian Journal of Pain","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2024-02-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139933566","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bridging the translational gap: adenosine as a modulator of neuropathic pain in preclinical models and humans 缩小转化差距:腺苷作为临床前模型和人类神经性疼痛的调节剂
IF 1.6 Q2 Medicine Pub Date : 2023-12-11 DOI: 10.1515/sjpain-2023-0048
Lars Arendt-Nielsen, Henrik Klitgaard, Stine N. Hansen
Abstract Objectives This review aims to analyse the published data on preclinical and human experimental and clinical adenosine modulation for pain management. We summarise the translatability of the adenosine pathway for further drug development and aim to reveal subgroups of pain patients that could benefit from targeting the pathway. Content Chronic pain patients suffer from inadequate treatment options and drug development is generally impaired by the low translatability of preclinical pain models. Therefore, validating the predictability of drug targets is of high importance. Modulation of the endogenous neurotransmitter adenosine gained significant traction in the early 2000s but the drug development efforts were later abandoned. With the emergence of new drug modalities, there is a renewed interest in adenosine modulation in pain management. In both preclinical, human experimental and clinical research, enhancing adenosine signalling through the adenosine receptors, has shown therapeutic promise. A special focus has been on the A1 and A3 receptors both of which have shown great promise and predictive validity in neuropathic pain conditions. Summary Adenosine modulation shows predictive validity across preclinical, human experimental and clinical investigations. The most compelling evidence is in the field of neuropathic pain, where adenosine has been found to alleviate hyperexcitability and has the potential to be disease-modifying. Outlook Adenosine modulation show therapeutic potential in neuropathic pain if selective and safe drugs can be developed. New drug modalities such as RNA therapeutics and cell therapies may provide new options.
摘要目的本综述旨在分析已发表的临床前、人体实验和临床腺苷调节疼痛管理的数据。我们总结了腺苷途径的可翻译性,以便进一步的药物开发,并旨在揭示可以从靶向该途径中受益的疼痛患者亚组。慢性疼痛患者的治疗选择不足,药物开发通常受到临床前疼痛模型可翻译性低的影响。因此,验证药物靶点的可预测性是非常重要的。内源性神经递质腺苷的调节在21世纪初获得了显著的关注,但药物开发工作后来被放弃。随着新的药物模式的出现,有一个新的兴趣腺苷调节疼痛管理。在临床前、人体实验和临床研究中,通过腺苷受体增强腺苷信号传导已显示出治疗前景。特别关注的是A1和A3受体,这两种受体在神经性疼痛条件下都显示出很大的希望和预测有效性。腺苷调节在临床前、人体实验和临床研究中显示出预测有效性。最令人信服的证据是在神经性疼痛领域,腺苷已被发现可以缓解过度兴奋性,并具有改善疾病的潜力。展望如果能够开发出选择性和安全的药物,腺苷调节在神经性疼痛中显示出治疗潜力。新的药物模式,如RNA疗法和细胞疗法可能提供新的选择。
{"title":"Bridging the translational gap: adenosine as a modulator of neuropathic pain in preclinical models and humans","authors":"Lars Arendt-Nielsen, Henrik Klitgaard, Stine N. Hansen","doi":"10.1515/sjpain-2023-0048","DOIUrl":"https://doi.org/10.1515/sjpain-2023-0048","url":null,"abstract":"Abstract Objectives This review aims to analyse the published data on preclinical and human experimental and clinical adenosine modulation for pain management. We summarise the translatability of the adenosine pathway for further drug development and aim to reveal subgroups of pain patients that could benefit from targeting the pathway. Content Chronic pain patients suffer from inadequate treatment options and drug development is generally impaired by the low translatability of preclinical pain models. Therefore, validating the predictability of drug targets is of high importance. Modulation of the endogenous neurotransmitter adenosine gained significant traction in the early 2000s but the drug development efforts were later abandoned. With the emergence of new drug modalities, there is a renewed interest in adenosine modulation in pain management. In both preclinical, human experimental and clinical research, enhancing adenosine signalling through the adenosine receptors, has shown therapeutic promise. A special focus has been on the A1 and A3 receptors both of which have shown great promise and predictive validity in neuropathic pain conditions. Summary Adenosine modulation shows predictive validity across preclinical, human experimental and clinical investigations. The most compelling evidence is in the field of neuropathic pain, where adenosine has been found to alleviate hyperexcitability and has the potential to be disease-modifying. Outlook Adenosine modulation show therapeutic potential in neuropathic pain if selective and safe drugs can be developed. New drug modalities such as RNA therapeutics and cell therapies may provide new options.","PeriodicalId":47407,"journal":{"name":"Scandinavian Journal of Pain","volume":null,"pages":null},"PeriodicalIF":1.6,"publicationDate":"2023-12-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138633027","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Frontmatter 头版头条
Q2 Medicine Pub Date : 2023-10-01 DOI: 10.1515/sjpain-2023-frontmatter4
{"title":"Frontmatter","authors":"","doi":"10.1515/sjpain-2023-frontmatter4","DOIUrl":"https://doi.org/10.1515/sjpain-2023-frontmatter4","url":null,"abstract":"","PeriodicalId":47407,"journal":{"name":"Scandinavian Journal of Pain","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135850008","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Scandinavian Journal of Pain
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1